Flerie

27,20 SEK

+2,64%

Mindre end 1K følgere

FLERIE

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Kvartalsdata

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Flerie

Q4/242024Q1/25Q2/25Q3/25Q4/252025Q1/26
Omsætning0,1
EBITDA-82,2-274,2-181,0167,2-146,7-538,8-699,5-62,9
EBIT-82,5-275,0-181,2167,0-146,9-539,0-700,1-63,0
EBIT-%-275.000,0 %
Overskud før skat-60,0-227,9-257,5174,2-135,9-538,7-757,9-61,5
Netto indkomst-64,0-228,0-251,0173,5-138,5-540,9-756,9-61,5